Vivimed Labs share news, announcements and annual reports
NSE: VIVIMEDLABBSE: 532660Pharmaceuticals & BiotechnologySmall Cap
Vivimed Labs Limited · Face value ₹2 Face value. The nominal value of one share as the company issued it, the unit its share capital is counted in and a dividend can be stated as a percentage of; it has no link to the share price. Face value in the glossary · Listed Aug 2005
Last close ₹5.53down ₹0.11 (1.95%)
Share price at the NSE close on 30 Oct 2026. Previous close ₹5.64.
30 Oct: open ₹5.62, high ₹5.64, low ₹5.53
- Delivery only: shares bought must be paid for in full, with no selling on the same day.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies. Market capitalisation: how it is worked out
- ₹46 Cr3,293rd largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit. Price to earnings, trailing: how it is worked out
- No recent results
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. Price to book: how it is worked out
- No recent results
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- Volume, NSEVolume. Shares traded on the last trading day. Volume in the glossary
- 3,267
Vivimed Labs share news and announcements
642 announcements, routine notices left out, newest first. Page 12 of 13.
Sep 2011
5 Sep · Meeting
(1) Annual General Meeting of the Company will be held on September 30, 2011. (2) The Register of Members and Share Transfer Books will remain closed from September 28, 2011 to September 30, 2011 (Both Days Inclusive) for the purpose of Annual General Meeting and declaration of dividend.
Aug 2011
5 Aug · Board meeting
Inter alia, to consider, approve and take on record the unaudited financial results of the Company for the quarter ended June 30, 2011.
Jul 2011
12 Jul · Business
Management Committee of the Board of Directors of the Company at their meeting held on July 11, 2011 have allotted 4,49,789 equity shares on preferential basis pursuant to (1) Special Resolution passed by the shareholders of the Company at their extra ordinary general meeting held on June 20, 2011, under Section 81 (1A) of Companies Act, 1956 and the Preferential Issue Regulations under Securities and Exchange Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2009 as amended from time to time. (2) Agreement and Plan of merger by and between Vivimed Labs Ltd, Vivimed Labs USA Inc., Har-Met International Inc., Mr. William F. Harvey and Mr. Arvind Mehta (Mr. William F. Harvey and Mr. Arvind Mehta being shareholders of Har-Met International Inc.) , dated August 03, 2009.7 Jul · Updates
As part of its global expansion strategy 'Vivimed Labs Ltd.' has floated the following overseas subsidiaries, either directly/through its subsidiary Companies: (1) Vivimed Labs Mauritius Ltd., Mauritius; (2) Vivimed Labs UK Ltd., UK; and (3) Vivimed Labs Spain, SL, Spain.
Jun 2011
23 Jun · FCCBs
(IFC) International Finance Corporation (World Bank Group) has entered into FCCB subscription Agreement with Vivimed labs Limited, for subscribing to FCCB's, on private placement basis to the tune of USD 7.5 Million.
May 2011
30 May · Board meeting
Board of Directors of the Company at its meeting held on May 27, 2011 has taken following decisions: (1) Approved the issuance and allotment, by way of a private placement, unsecured foreign currency convertible bonds (the "FCCBs") up to an amount in the aggregate not exceeding US$ 7.50 Million (approximately Rs. 34 crores) to the International Finance Corporation. The relevant date for calculating the floor price of FCCBs shall be May 27,2011. (2) Approved calling of Extra Ordinary General Meeting on June 20, 2011, to seek shareholder approval for preferential issue of equity shares.30 May · Dividend
Board of Directors of the Company at its meeting held on May 27, 2011 have recommended a final dividend of Rs.2/- per equity share for the financial year 2010-11.18 May · Board meeting
Inter alia to consider and approve Audited Financial results of the Company for the quarter and year ended March 31, 2011.10 May · Board meeting
Board of Directors of the Company at its meeting held on May 06, 2011 approved the following : (1) Passed the resolution under Section 372A of the Companies Act, 1956 to make loan and/or to give guarantee, or to provide security, in connection with the loan made by any other person to or other person by and/or to acquire, by way of subscription, purchase or otherwise the securities of any company up to an amount of Rs.500 crores; (2) Passed resolution approving calling for extra-ordinary general meeting on May 31, 2011.2 May · Results
Company has opted for submitting audited financial results for financial year 2010-11, within 60 (sixty) days from end of financial year.
Jan 2011
18 Jan · Board meeting
Inter alia to consider, approve and take on record the Unaudited Financial Results of the Company for quarter and nine months ended December 31, 2010.
Dec 2010
Nov 2010
Oct 2010
12 Oct · Board meeting
Inter alia to consider and approve the unaudited financial results for the quarter ended on September 30, 2010.11 Oct · Board meeting
Board of Directors of the Company at the Board Meeting held on October 09, 2010 have inter alia taken the following decisions: (1) To raise funds through Global Depository Receipts (GDRs) and/or American Depository Receipts (ADRs) convertible into Equity Share and/or Foreign Currency Convertible Bonds (FCCBs) or Warrants convertible into depository receipts with underlying Equity Shares/Equity Shares ("Securities") and/or Qualified Institutional Placement upto an amount of US$ 25 million inclusive of premium; (2) To increase authorized share capital of the Company to Rs.20 Crores; (3) To increase FII Investment limits upto 49% of paid up shares capital; (4) To call for an Extra-Ordinary General Meeting of members of the Company on November 06, 2010.11 Oct · Updates
Company has received "in-principle" approval from Government of India, Ministry of Commerce & Industry, Department of Commerce, New Delhi for development, operation and maintenance of a sector specific 'Special Economic Zone' for Chemicals & Pharmaceuticals - (Bulk / APIs / Formulations) over an area of 131.68 hectares at Srikakulam District of Andhra Pradesh.7 Oct · Miscelleneous
Vivimed Labs Limited had informed the Exchange that Management Committee of the Board of Directors of the Company has allotted 199,112 differential Equity Shares against conversion of Foreign Currency Convertible Bonds. The Company has now informed the Exchange vide its letter dated October 6, 2010 that: "199,112 additional equity shares have been allotted as per terms of Offering Circular to bondholders of 2500 foreign currency convertible bonds."6 Oct · Board meeting
To consider further capital issue.4 Oct · Business
Management Committee of the Board of Directors of the Company has allotted 199,112 differential Equity Shares against conversion of Foreign Currency Convertible Bonds.
Sep 2010
Aug 2010
17 Aug · Meeting
Board of Directors of the Company at its meeting held on August 16, 2010 following other decisions of the Board are informed: (1) Annual General Meeting of the Company will be held on September 18, 2010. (2) The Register of Members and Share Transfer Books will remain closed from September 14, 2010 to September 18, 2010 (Both Days Inclusive) for the purpose of Annual General Meeting and declaration of dividend.17 Aug · Dividend
Board of Directors of the Company at its meeting convened on August 14, 2010 and adjourned to August 16, 2010, has decided to recommend a dividend of Rs.1.50/- (15%) per share on 99,64,904 equity share of nominal value Rs.10 each aggregating to Rs.1,49,47,356, subject to approval of the shareholders at their Annual General Meeting.5 Aug · Board meeting
Inter alia to: (1) Consider and approve the unaudited financial results for the quarter ended June 30, 2010 along with the related segment wise financial results.(2) Fix the date, time and venue of Annual General Meeting and to approve the draft notice convening the Annual General Meeting.(3) Fix the date of closure of Register of Members and Share Transfer Books of the Company for the purpose of dividend and Annual General Meeting.
Jun 2010
29 Jun · Management
Board of Directors of the Company has appointed Mr. Nixon Patel as an Additional Director of the Company with effect from June 28, 2010. Mr. Nixon Patel has been appointed as an Independent Director on the Board.
May 2010
31 May · Management
At the Board meeting of the Company held on May 29, 2010, the Board has approved the appointment of Mr. Fahim Aslam Khan as Company Secretary and Compliance Officer of the Company.20 May · Board meeting
Inter alia to consider and take on record the audited standalone and consolidated financial results for the financial year ended on March 31, 2010.20 May · Updates
Name of James Robinson Limited (a wholly owned subsidiary of Vivimed Labs Limited situated at UK) has been changed to Vivimed Labs Europe Ltd.15 May · Results
Management of the Company has opted to submit audited financial results for the entire financial year within 60 days from the end of financial year 2009-2010.
Apr 2010
26 Apr · Board meeting
Board of Directors at their meeting held on April 24, 2010 resolved to issue 14,90,000 warrants convertible into Equity Shares of Rs. 10/- each at a premium of Rs. 140/- each to promoters and others for which the Company has already received In-principle approval from the Exchanges.20 Apr · Board meeting
To consider receipt of Warrant Application Money and allot warrants to the allottees.
Mar 2010
8 Mar · Meeting
Members of the Company at their Extraordinary General Meeting held on March 05, 2010, have duly approved the special business as specified in notice convening the meeting viz; Allotment of Warrants on Preferential Basis. Members have resolved for preferential allotment of 15,00,000 Warrants to parties specified in Notice convening the Extra Ordinary General Meeting at a price of Rs. 150 per warrant.
Feb 2010
8 Feb · Board meeting
Board of Vivimed Labs Limited at their meeting held on February 05, 2010 passed resolution to call for and convene Extra Ordinary General Meeting of the shareholders on March 05, 2010 to obtain consent / approval of the members for: Issue of upto 15,00,000 Warrants on preferential basis at a issue price of Rs. 150 per warrant determined in accordance with relevant SEBI Regulations, convertible into Equity Shares of Rs. 10 fully paid up for each warrant, at the option of warrant holders, within 18 months from the date of allotment of warrants.3 Feb · Board meeting
Members of the Company in their Extra Ordinary General Meeting held on November 21, 2009 approved issue of Warrants on Preferential Basis. However, due to technical reasons, Company could not proceed with allotment of warrants. Hence Board of the Company, shall meet on February 05, 2010 to consider and decide on date of EGM to be held to reconsider and consent to allot Warrants on preferential basis, to the same persons approved in the EGM held on November 21, 2009.
Jan 2010
21 Jan · Board meeting
Meeting on 29 Jan 2010: “Unaudited Financial Results for the qtr ended Dec 31, 2009”
Oct 2009
20 Oct · Meeting
Board of Directors of the Company at their meeting held on October 16, 2009 passed resolution to call for and convene Extra Ordinary General Meeting of the Member on November 21, 2009 to obtain consent/ approval of the members for : Preferential Issue of upto 15,00,000 Warrants, Convertible into Equity Shares at a issue price of Rs.120 per warrant determined in accordance with relevant SEBI Regulations, at the option of warrant holders, within 18 months from the date of allotment of warrants, at one equity share of Rs.10 fully paid up for each warrant.20 Oct · Board meeting
Meeting on 27 Oct 2009: “Unaudited Financial Results for the Qtr ended Sept 30, 2009”12 Oct · Board meeting
To consider issue of Preferential Shares / Warrants and other business as per agenda.6 Oct · Meeting
Outcome of Annual General Meeting held on September 30, 2009. The details of the same shall be available on the NSE website (http://www.nseindia.com) under: Corporates > Latest Announcements and on the Extranet Server (/Common/Corporate Announcements). For more details click here.
Sep 2009
24 Sep · Meeting
Annual General Meeting of the Members of the Company will be held on September 30, 2009.